Body surface area [Regulatives / Guidelines]

posted by Rock – India, 2018-02-12 10:47 (3060 d 08:48 ago) – Posting: # 18407
Views: 2,086

Dear Members
Please let me know, if body surface area (BSA) needs to be used for dose calculation in case of non-NTI drugs and in healthy subjects.

Also, confirm if an infusion study with long washout period which anticipated to significant change in weight, results in different dosages across the periods will require dose normalization?

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
353 visitors (0 registered, 353 guests [including 22 identified bots]).
Forum time: 20:35 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5